Quanterix (QTRX) CEO Talks Digital Biomaker Analysis Technology

Quanterix (QTRX) is a provider of ultra-sensitive digital biomaker analysis technology and advances the science of precision health. Its customers include 19 of the top 20 pharmaceutical companies. The company's chariman and CEO, Kevin Hrusovsky, weighs in on the 1Q revenue increasing 58% year-over-year to $24.9M. The stock is down more than 20% in May.